Clinical Trial Update: A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of SHR-3045 in healthy subjects. Rheumatoid arthritis is listed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SHR-3045

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Rheumatoid Arthritis | Phase 1 | Status: ACTIVE_NOT_RECRUITING